Stage IVA Colorectal Cancer Terminated Phase 2 Trials for Oxybuprocaine (DB00892)

IndicationStatusPhase
DBCOND0068496 (Stage IVA Colorectal Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02508077FOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal CancerTreatment